Wall Street Associates’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-6,400
| Closed | -$232K | – | 218 |
|
|
2016
Q3 | $232K | Hold |
6,400
| – | – | 0.08% | 213 |
|
|
2016
Q2 | $217K | Buy |
+6,400
| New | +$217K | 0.09% | 209 |
|
|
2016
Q1 | – | Sell |
-6,400
| Closed | -$312K | – | 284 |
|
|
2015
Q4 | $312K | Buy |
+6,400
| New | +$312K | 0.09% | 271 |
|
|
2015
Q3 | – | Sell |
-76,000
| Closed | -$2.41M | – | 355 |
|
|
2015
Q2 | $2.41M | Sell |
76,000
-3,000
| -4% | -$94.9K | 0.23% | 116 |
|
|
2015
Q1 | $3.01M | Sell |
79,000
-3,700
| -4% | -$141K | 0.28% | 108 |
|
|
2014
Q4 | $3.22M | Sell |
82,700
-500
| -0.6% | -$19.5K | 0.31% | 102 |
|
|
2014
Q3 | $2.52M | Sell |
83,200
-9,900
| -11% | -$299K | 0.26% | 116 |
|
|
2014
Q2 | $3.16M | Buy |
93,100
+300
| +0.3% | +$10.2K | 0.27% | 121 |
|
|
2014
Q1 | $3.2M | Sell |
92,800
-1,000
| -1% | -$34.5K | 0.26% | 127 |
|
|
2013
Q4 | $3.71M | Buy |
93,800
+6,300
| +7% | +$249K | 0.3% | 117 |
|
|
2013
Q3 | $1.95M | Buy |
+87,500
| New | +$1.95M | 0.18% | 164 |
|